Cargando…

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4

BACKGROUND: Two transport media, PreservCyt and SurePath, are widely used for cervical cytology screening. There are concerns that they may perform differently for HPV testing. OBJECTIVES: A comparison of the performance of six different HPV tests in SurePath and PreservCyt in a referral population...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuzick, Jack, Ahmad, Amar S., Austin, Janet, Cadman, Louise, Ho, Linda, Terry, George, Kleeman, Michelle, Ashdown-Barr, Lesley, Lyons, Deirdre, Stoler, Mark, Szarewski, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994427/ https://www.ncbi.nlm.nih.gov/pubmed/27498250 http://dx.doi.org/10.1016/j.jcv.2016.06.015

Ejemplares similares

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study
por: Cadman, Louise, et al.
Publicado: (2015)

The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry
por: Bjønness-Jacobsen, Ellen Cathrine, et al.
Publicado: (2016)

Comparing the performance of six human papillomavirus tests in a screening population
por: Cuzick, J, et al.
Publicado: (2013)

Human papillomavirus (HPV) detection in vaginal self-samples: evaluation of eNat® as an alternative suspension medium to ThinPrep®PreservCyt® for vaginal swabs
por: Giubbi, Chiara, et al.
Publicado: (2022)

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions
por: Cuzick, Jack, et al.
Publicado: (2014)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Combining Endometrium Sampling Device and SurePath Preparation to Screen for Endometrial Carcinoma: A Validation Study
por: Wen, Jia, et al.
Publicado: (2015)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Impact of SurePath(®) liquid-based preparation in cytological analysis of peritoneal washing in practice of gynecologic oncology
por: Tyagi, Ruchita, et al.
Publicado: (2017)

Tubercular granulomas in Bronchoalveolar lavage fluid in SurePath liquid-based cytology smears: An enigmatic finding
por: Badyal, Rama Kumari, et al.
Publicado: (2021)

Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples
por: Kim, Jiyoung, et al.
Publicado: (2019)

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
por: Ejegod, Ditte Møller, et al.
Publicado: (2016)

A comparative analysis of conventional and SurePath liquid-based cervicovaginal cytology: A study of 140 cases
por: Sharma, Jyotsna, et al.
Publicado: (2016)

Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study
por: Cadman, Louise, et al.
Publicado: (2012)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens
por: Nance, Keith V
Publicado: (2013)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017)

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility
por: Day, Sarah J, et al.
Publicado: (2004)

APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
por: Fontaine, Daniel, et al.
Publicado: (2012)

Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method
por: Østbye, Kirsten Margrethe, et al.
Publicado: (2019)

Diagnostic Utility and Efficacy of Conventional Versus SurePath® Liquid-based Cytology in Head and Neck Pathology: A Study in an Indian Tertiary Care Hospital
por: Sharma, Sonam, et al.
Publicado: (2018)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
por: Ejegod, Ditte Møller, et al.
Publicado: (2021)

A prospective randomized noninferiority trial comparing conventional smears and SurePath(TM) liquid-based cytology in endoscopic ultrasound-guided sampling of esophageal, gastric, and duodenal lesions
por: Jun, Jae Chang, et al.
Publicado: (2023)

Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting
por: Szarewski, Anne, et al.
Publicado: (2007)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

Collection of the BD SurePath Pap Test with a broom device plus endocervical brush improves disease detection when compared to the broom device alone or the spatula plus endocervical brush combination
por: Davis-Devine, Sharon, et al.
Publicado: (2008)

Awareness of human papillomavirus among women attending a well woman clinic
por: Waller, J, et al.
Publicado: (2003)

Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance
por: Louie, Karly S., et al.
Publicado: (2018)

HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
por: Szarewski, A, et al.
Publicado: (2011)

Performance of the Xpert HPV assay in women attending for cervical screening
por: Cuzick, Jack, et al.
Publicado: (2015)

The Sure Foundation
Publicado: (1889)

Cannot write session to /tmp/vufind_sessions/sess_cqp98k4osin8obc204ealf7fna